The World Health Organisation, WHO, Technical Advisory Group on Vaccine Research has recommended a clinical trial in the Democratic Republic of Congo to evaluate the Ervebo vaccine against the Bundibugyo virus. Ervebo is the only licensed vaccine against Ebola. The WHO is working with partners to begin the trial as soon as possible. READ ALSO: DR Congo Intensifies Response to Ebola OutbreakThe situation is also affecting pregnant women. They have reached more than 2.4 million people with information on Ebola prevention and early detection and carried out more than 500,000 household visits.